10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Characterization of age/sex and the regional distribution of mGluR5 availability in the healthy human brain measured by high-resolution [(11)C]ABP688 PET.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Metabotropic glutamate receptor type 5 (mGluR5) is a G protein-coupled receptor that has been implicated in several psychiatric and neurological diseases. The radiopharmaceutical [(11)C]ABP688 allows for in vivo quantification of mGluR5 availability using positron emission tomography (PET). In this study, we aimed to detail the regional distribution of [(11)C]ABP688 binding potential (BPND) and the existence of age/sex effects in healthy individuals.

          Related collections

          Author and article information

          Journal
          Eur. J. Nucl. Med. Mol. Imaging
          European journal of nuclear medicine and molecular imaging
          Springer Nature
          1619-7089
          1619-7070
          Jan 2016
          : 43
          : 1
          Affiliations
          [1 ] Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, 3801 University Street, Room 786, Montreal, Quebec, H3A 2B4, Canada. jonathan.dubois@mail.mcgill.ca.
          [2 ] The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD, USA.
          [3 ] Translational Neuroimaging Laboratory, McGill Center for Studies in Aging, Douglas Mental Health University Institute, McGill University, Montreal, Canada.
          [4 ] Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, 3801 University Street, Room 786, Montreal, Quebec, H3A 2B4, Canada.
          [5 ] PET Unit, McConnell Brain Imaging Center, Montreal Neurological Institute, McGill University, Montreal, Canada.
          [6 ] Division of Imaging Sciences and Biomedical Engineering, King's College London, St. Thomas' Hospital, London, UK.
          [7 ] Department of Epidemiology, Biostatistics and Occupational health, McGill University, Montreal, Canada.
          [8 ] Department of Psychiatry, Douglas Mental Health University Institute / Douglas Institut Universitaire en Santé Mentale, Montreal, Canada.
          [9 ] Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, 3801 University Street, Room 786, Montreal, Quebec, H3A 2B4, Canada. eliane.kobayashi@mcgill.ca.
          Article
          10.1007/s00259-015-3167-6
          10.1007/s00259-015-3167-6
          26290423
          41599c34-3715-428d-877a-2985179adcfa
          History

          Healthy controls,Metabotropic glutamate receptor 5,Positron emission tomography,[11C]ABP688

          Comments

          Comment on this article